APOBEC3A and non-small cell lung carcinoma: In the NCI-H2347 non-small cell lung cancer cell line, we found that type I interferon (IFN) treatment upregulated endogenous APOBEC3A expression (Appendix Fig. S5a) which correlated with an increase in replication tract length (Fig. 6I).